Fairfax, Va., March 4, 2010 - The Radiation Oncology Institute (ROI) has issued a request for proposals to conduct a national research needs assessment for radiation oncology. The results obtained through this national assessment will be the main tool ROI will use to set the national research needs agenda and frame its research priorities. These priorities will then be used by ROI to determine its research projects.
“In order for the Radiation Oncology Institute to establish a credible national research agenda, set priorities for fulfilling the agenda, and formulate sophisticated processes to implement research for the profession, it is important for the us to conduct a full-scale evaluation of research needs across the radiation oncology profession and other related industries,” said Theodore S. Lawrence, M.D., Ph.D., FASTRO, President of the ROI Board of Trustees. “We intend to retain a third party to conduct this needs assessment to ensure objectivity in the process.”
ROI hopes that through this RFP process they will be able to identify a vendor who can perform a baseline needs assessment through a variety of methods including interviews, focus groups and surveys of thought leaders in radiation oncology.
The Radiation Oncology Institute (ROI) is a non-profit, 501 (c)(3) foundation created in 2006 by the American Society for Radiation Oncology (ASTRO) Board of Directors to support research and education efforts around the world that enhance and confirm the critical role of radiation therapy in improving cancer treatment. ROI strategically funds research on new and existing radiation therapy treatments to identify links between best practices and improved outcomes, to evaluate the efficacy and cost-benefit of radiation therapy and to foster multi-institutional research in radiation oncology. The ROI recently launched the National Radiation Oncology Registry (NROR) pilot program to collect standardized information about patient care to help inform quality improvement initiatives and provide meaningful benchmarks for the radiation oncology field.